MRNA vs MWYN · rev $145.0M vs rev $4.2M
Moderna Inc (MRNA) versus Marwynn Holdings, Inc. Common stock (MWYN) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Marwynn Holdings, Inc. Common stock (MWYN) is a furnishings, fixtures & appliances company listed on US.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported MWYN revenue for 2026-04-30 was $4.2M. Net income was -$3.9M. Revenue was down 61.8% from 2025-04-30 to 2026-04-30. MWYN currently screens at market cap $16.8M.
MRNA currently screens at market cap $24.52B. MWYN currently screens at market cap $16.8M.
Not investment advice. Open the MRNA and MWYN stock pages for the full models.
Not investment advice.